Thema
Letter
Comment
3.568
COVID-19
1.557
Case Reports
761
Research Support, Non-U.S. Gov't
649
SARS-CoV-2
498
Antiviral Agents
208
Hydroxychloroquine
198
4QWG6N8QKH
195
EC 3.4.15.1
160
Peptidyl-Dipeptidase A
160
Coronavirus
157
Angiotensin-Converting Enzyme 2
149
EC 3.4.17.23
149
ACE2 protein, human
135
Antibodies, Viral
135
Research Support, N.I.H., Extramural
135
RNA, Viral
121
coronavirus
116
Aerosols
111
Review
108
Anticoagulants
104
Antibodies, Monoclonal, Humanized
97
Biomarkers
95
Covid-19
93
Cytokines
87
Clinical Trial Protocol
85
Observational Study
84
Pandemic
83
Multicenter Study
77
Immunoglobulin G
74
Randomised controlled trial
73
Comparative Study
70
Immunosuppressive Agents
68
83905-01-5
67
Angiotensin-Converting Enzyme Inhibitors
67
Azithromycin
67
COVID-19 Vaccines
63
protocol
63
Spike Glycoprotein, Coronavirus
60
Anti-Inflammatory Agents
56
Fibrin Fibrinogen Degradation Products
56
fibrin fragment D
56
tocilizumab
55
Adrenal Cortex Hormones
54
I031V2H011
54
O3J8G9O825
54
Ritonavir
54
Angiotensin Receptor Antagonists
53
Anti-Bacterial Agents
53
mehr ...